Eur Rev Med Pharmacol Sci 2022; 26 (17): 6215-6220

DOI: 10.26355/eurrev_202209_29639

Transcutaneous electric acupoint stimulation reduces rocuronium injection-related pain: a prospective randomized controlled study

M. Yildiz, B. Kozanhan

Anesthesiology and Reanimation Department, University of Health Science, Konya City Hospital, Konya, Turkey. drmunise@hotmail.com

 


OBJECTIVE: Various approaches have been suggested to reduce the pain and discomfort associated with rocuronium injection. This randomized controlled trial aimed at exploring the effectiveness of transcutaneous electrical acupoint stimulation (TEAS), a non-invasive modality to reduce the pain associated with rocuronium injection.

PATIENTS AND METHODS: 60 patients undergoing elective general anesthesia were recruited and randomly allocated to the TEAS or placebo TEAS (no electrical output) groups. TEAS consisted of 30 min of stimulation at a frequency of 2/100 Hz and an intensity of 6-9 mA on Hegu (LI4) and Neiguan (PC6) before anesthesia induction. A blinded observer evaluated the pain using a 4-point pain scale.

RESULTS: The overall incidence of rocuronium injection-related pain was significantly lower in the TEAS group than that in the placebo TEAS group (40% and 86.7%, respectively). The incidence of no or mild pain was significantly higher in the TEAS group (100%, p<0,001) group than that in the placebo TEAS group (50%).

CONCLUSIONS: Pretreatment with TEAS effectively reduced the frequency and severity of pain associated with rocuronium injection.

Free PDF Download

To cite this article

M. Yildiz, B. Kozanhan
Transcutaneous electric acupoint stimulation reduces rocuronium injection-related pain: a prospective randomized controlled study

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 17
Pages: 6215-6220
DOI: 10.26355/eurrev_202209_29639